KKR to acquire Japanese CDMO Bushu Pharmaceuticals from BPEA EQT
American global investment company Kohlberg Kravis Roberts & Co (KKR) will acquire all shares of Bushu Pharmaceuticals from Asian private equity firm BPEA EQT for an undisclosed amount. Post-closing, KKR intends to fast-track Bushu Pharmaceuticals’ growth and further establish the company as a major contract development and manufacturing organization (CDMO) in Japan and international pharmaceutical […]